Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$10,099 Mln
Revenue (TTM)
$5,935 Mln
Net Profit (TTM)
$419 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
18.1
P/B Ratio
4.1
Industry P/E
--
EV/EBITDA
9
Div. Yield
0.7 %
Debt to Equity
1.1
Book Value
$23.9
EPS
$5.6
Face value
--
Shares outstanding
99,416,162
CFO
$6,567.20 Mln
EBITDA
$8,704.90 Mln
Net Profit
$2,879.40 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Encompass Health Corp (EHC)
| -7.8 | -10.3 | -9.0 | 0.2 | 23.8 | 8.9 | 13.0 |
|
BSE Sensex
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Encompass Health Corp (EHC)
| 14.9 | 38.0 | 11.6 | 15.2 | -19.9 | 21.4 | 14.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Encompass Health Corp (EHC)
|
97.9 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 |
| 14.0 | 3,315.2 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 381.8 | 5,670.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 21.9 | 5.6 | |
| 53.5 | 2,697.1 | 941.5 | 105.7 | 14.5 | 29.4 | 25.8 | 7.2 | |
| 23.5 | 5,434.1 | 2,347.6 | 128.4 | 4.9 | 25.2 | 46.7 | 10.0 | |
| 29.1 | 4,649.3 | 5,649.5 | 207.6 | 7.0 | 15.2 | 23.1 | 3.5 | |
| 21.5 | 2,681.6 | 2,122.8 | 22.9 | 1.9 | 0 | 120.4 | 3.6 | |
| 61.9 | 4,818.9 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.4 | |
| 13.4 | 3,815.1 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.7 | 6.3 | |
| 200.8 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 |
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a... major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama. Read more
CEO, President & Director
Mr. Mark J. Tarr
CEO, President & Director
Mr. Mark J. Tarr
Headquarters
Birmingham, AL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Encompass Health Corp (EHC) is $97.88 (NYSE) as of 19-Mar-2026 14:42 EDT. Encompass Health Corp (EHC) has given a return of 23.83% in the last 3 years.
The P/E ratio of Encompass Health Corp (EHC) is 18.08 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.12
|
4.44
|
|
2024
|
20.73
|
4.57
|
|
2023
|
19.24
|
4.11
|
|
2022
|
22.25
|
4.60
|
|
2021
|
15.85
|
3.42
|
The 52-week high and low of Encompass Health Corp (EHC) are Rs 127.99 and Rs 92.77 as of 20-Mar-2026.
Encompass Health Corp (EHC) has a market capitalisation of $ 10,099 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Encompass Health Corp (EHC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-1.81
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.